Antigen-loaded Monocyte Administration and Flt3 Ligand Augment the Antitumor Efficacy of Immune Checkpoint Blockade in a Murine Melanoma Model
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antigen-loaded Monocyte Administration and Flt3 Ligand Augment the Antitumor Efficacy of Immune Checkpoint Blockade in a Murine Melanoma Model
Authors
Keywords
-
Journal
JOURNAL OF IMMUNOTHERAPY
Volume 46, Issue 9, Pages 333-340
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-09-22
DOI
10.1097/cji.0000000000000487
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systemic vaccination induces CD8+ T cells and remodels the tumor microenvironment
- (2022) Faezzah Baharom et al. CELL
- Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses
- (2021) Fan Huang et al. JOURNAL OF CLINICAL INVESTIGATION
- The Flt3L/Flt3 Axis in Dendritic Cell Biology and Cancer Immunotherapy
- (2021) Francisco J. Cueto et al. Cancers
- Dendritic cell paucity in mismatch repair–proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy
- (2021) William W. Ho et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
- (2020) Ugur Sahin et al. NATURE
- A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
- (2020) Patrick A. Ott et al. CELL
- Antigen-loaded monocyte administration induces potent therapeutic antitumor T cell responses
- (2019) Min-Nung Huang et al. JOURNAL OF CLINICAL INVESTIGATION
- CD103+ Cell Growth Factor Flt3L Enhances the Efficacy of Immune Checkpoint Blockades in Murine Glioblastoma Model
- (2018) Xiaolin Miao et al. ONCOLOGY RESEARCH
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
- (2018) Moshe Sade-Feldman et al. CELL
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- UV-induced somatic mutations elicit a functional T cell response in the YUMMER1.7 mouse melanoma model
- (2017) Jake Wang et al. Pigment Cell & Melanoma Research
- CTLA-4 and PD-1 Pathways
- (2016) Elizabeth I. Buchbinder et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers
- (2015) N Anandasabapathy et al. BONE MARROW TRANSPLANTATION
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of ICOS on Human Melanoma-Infiltrating CD4+CD25highFoxp3+ T Regulatory Cells: Implications and Impact on Tumor-Mediated Immune Suppression
- (2014) L. Strauss et al. JOURNAL OF IMMUNOLOGY
- Dendritic Cells in Cancer Immunotherapy Clinical Trials: Are We Making Progress?
- (2013) Lisa H. Butterfield Frontiers in Immunology
- Safety and Immunogenicity of Vaccination With MART-1 (26–35, 27L), gp100 (209–217, 210M), and Tyrosinase (368–376, 370D) In Adjuvant With PF-3512676 and GM-CSF In Metastatic Melanoma
- (2012) Ahmad A. Tarhini et al. JOURNAL OF IMMUNOTHERAPY
- gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
- (2011) Douglas J. Schwartzentruber et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
- (2010) H. W. van Deventer et al. CANCER RESEARCH
- The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues
- (2008) Claudia Waskow et al. NATURE IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started